Biofrontera Inc. Annual Deferred Federal Income Tax Expense (Benefit) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Biofrontera Inc. annual/quarterly Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $0.000.
  • Biofrontera Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was $0.000.
Deferred Federal Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.